Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive Validity of Hypothesized Risk Factors for Superior Canal Dehiscence Syndrome.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

Chronic Rhinosinusitis and Nasal Polyps in Eosinophilic Granulomatosis With Polyangiitis: A Scoping Review.

International forum of allergy & rhinology·2026
Same author

The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.

BJU international·2026
Same author

Spatiotemporal Medicare Reimbursement Trends and Economic Clusters in Otologic/Neurotologic Surgery.

The Laryngoscope·2026
Same author

Anthropometric Measurements Inform Complete Concentric Collapse Status in Patients With Obstructive Sleep Apnea.

OTO open·2026
Same author

Diagnostic Performance of the Stenvers and Pöschl Planes on CT in the Evaluation of Superior Semicircular Canal Dehiscence.

AJNR. American journal of neuroradiology·2026

Related Experiment Video

Updated: Oct 31, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.2K

Measuring Quality of Life Following Robot-Assisted Radical Prostatectomy.

Graham R Hale1, Mohammed Shahait2, David I Lee3

  • 1Department of Urology, University of Illinois at Chicago, Chicago, IL, USA.

Patient Preference and Adherence
|June 30, 2021
PubMed
Summary

Robot-assisted radical prostatectomy (RARP) is a common prostate cancer treatment. Patient-reported outcomes (PRO) help understand quality of life impacts after RARP, aiding treatment decisions.

Keywords:
minimally invasive surgical procedurespatient-reported outcomes measuresprostatectomyprostatic neoplasmsrobotic surgery

More Related Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.0K
Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

430

Related Experiment Videos

Last Updated: Oct 31, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.2K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.0K
Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

430

Area of Science:

  • Urology
  • Oncology
  • Health Services Research

Background:

  • Prostate cancer (PCa) is the most common male malignancy, often diagnosed at localized stages with high cure rates.
  • Robot-assisted radical prostatectomy (RARP) and radiation therapy (RT) are primary treatments for localized PCa, offering similar oncologic outcomes but varying side effects.
  • Patient-reported outcomes (PRO) are increasingly used to assess health-related quality of life (HRQOL) impacts of PCa treatments, particularly RARP.

Purpose of the Study:

  • To review instruments for measuring quality of life after RARP.
  • To analyze PRO data concerning quality of life following RARP.
  • To identify future research directions for improving post-RARP quality of life.

Main Methods:

  • This is a narrative review.
  • Literature search for studies on quality of life after RARP.
  • Analysis of patient-reported outcome data.

Main Results:

  • Multiple instruments exist to measure quality of life after RARP.
  • PRO data reveals significant impacts of RARP on quality of life domains.
  • Understanding patient perspectives is crucial for evaluating RARP outcomes.

Conclusions:

  • Treatment choices for localized prostate cancer involve trade-offs between oncologic outcomes and quality of life.
  • Patient-reported data on side effects and quality of life post-RARP enhances preoperative counseling.
  • Informed patient choice between RARP and other treatments can be improved by understanding HRQOL data.